stockportfolio.pro
Stocks / ROIV vs STE
ROIV vs STE
Roivant Sciences Ltd. and STERIS plc side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Roivant Sciences Ltd. (ROIV) | STERIS plc (STE) | |
|---|---|---|
| Market cap | $20.5B | $20.8B |
| Revenue (latest FY) | $8.26M | $5.94B |
| Net income (latest FY) | $-299.77M | $782.30M |
| Revenue growth (5y CAGR) | -19.1% | 13.8% |
| Net margin | -3629.2% | 13.2% |
| Return on equity | -6.6% | 10.9% |
| P/E ratio | — | 26.8 |
| Dividend yield | — | 1.2% |
| Profitable years (of last 10) | 1 | 10 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ROIV — free Open STE — freeFrequently asked questions
Which is bigger, ROIV or STE?
STERIS plc is larger by market capitalization — $20.8B versus $20.5B.
Which grows faster, ROIV or STE?
Over the last five fiscal years, STERIS plc grew revenue faster — 13.8%/yr versus -19.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.